Proposed Biosite-Beckman Merger Clears Antitrust Hurdle
Biosite said this week that the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 had expired without a request from the US Federal Trade Commission for additional information about Biosite’s proposed merger with Beckman Coulter, removing one hurdle from the $1.55 billion deal to proceed.